Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study
ISRN Immunology · 2014
DOI: 10.1155/2014/295239 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISRN Immunology, 2014. Verfasst von Katharina Benita Sokoll und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Fondazione APS ONLUS, Italy, Senit Foundation, UK.
Abstract (Originalsprache)
Objective
The effect of statins on atherogenesis in systemic lupus erythematosus (SLE) is poorly known. To inform a wider trial we performed a pilot study evaluating the intima-media thickness of the common carotid artery (CIMT) and some oxidative [beta-2-glycoprotein-1 complexed with oxidised low density lipoprotein ( β 2 GPIoxLDL)], metabolic [paraoxonase (PON), nitrate ( NO 3 − ), nitrite ( NO 2 − ) and nitrotyrosine (NT)], inflammatory [C-reactive protein (CRP) and serum amyloid A (SAA)], and lipid markers before and after 1 year of treatment with 40 mg of oral atorvastatin (AT).
Methods
Randomised, double blind, placebo controlled pilot study on consecutive SLE patients: 17 SLE patients were randomised into the AT arm and 20 into the placebo arm. CIMT was measured by high-resolution sonography, PONa by a spectrophotometric method, NO 3 − and NO 2 − by a colorimetric assay and oxLDL- β 2 GPI, NT, CRP, and SAA by Elisa.
Results
After correction for age and disease duration oxLDL- β 2 GPI decreased by 27% ( P = 0.002 ) and PON/HDL ratio increased by 12% ( P = 0.01 ) but CIMT did not change.
Conclusion
This pilot study revealed a decrease of oxLDL- β 2 GPI (oxidant marker) and an increase of PON/HDL ratio (antioxidant activity) after AT indicating a favourable effect of the drug on atherogenic pathways that should be explored on larger trials.
Förderung
- Fondazione APS ONLUS, Italy
- Senit Foundation, UK
Zitieren
APA
Sokoll, K. B., Batuca, J., Lopez, L. R., Hensor, E., Emery, P., Alves, J. D., & Ames, P. R. J. (2014). Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study. ISRN Immunology. https://doi.org/10.1155/2014/295239
Vancouver
Sokoll KB, Batuca J, Lopez LR, Hensor E, Emery P, Alves JD, et al. Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study. ISRN Immunology. 2014. doi:10.1155/2014/295239
BibTeX
@article{Sokoll2014,
author = {Sokoll, Katharina Benita and Batuca, Joana and Lopez, Luis Romulo and Hensor, Elizabeth and Emery, Paul and Alves, José Delgado and Ames, Paul Richard Julian},
title = {Effects of Atorvastatin on Atherosclerosis and Atherogenesis in Systemic Lupus Erythematosus: A Pilot Study},
journal = {ISRN Immunology},
year = {2014},
doi = {10.1155/2014/295239}
}
EUVIMED